Mitazalimab (Anti-TNFRSF5 / CD40)

Mitazalimab (Anti-TNFRSF5 / CD40) a human agonist IgG1 antibody targeting CD40. It enhances the anti-tumor efficacy of a model cancer vaccine. MW :143.44 KD.
Supplier Selleck Chemicals
Product # A3088
Sku # A3088-1mg*25
Pricing 1mg*25, $2970.00
Feedback